SCHEMBL5340445

SCHEMBL5340445

CC[Pd]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28234556 0.72
Hydrochloric Acid SCHEMBL28293065 0.68
SCHEMBL9538379 0.67
Propane SCHEMBL286506 0.61
Propane SCHEMBL10956924 0.61 TSHR (0.43)
Propane SCHEMBL9246294 0.61
Propane SCHEMBL1021 0.61
Propane SCHEMBL9248656 0.61 TSHR (0.43)
Propane SCHEMBL11076973 0.55
Propane SCHEMBL5383086 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119264190-A Flexible monoaryl methyl alpha-diimine palladium (II) catalyst and application thereof in ethylene catalytic polymerization 安徽师范大学 2025-01-07 CN disclosed
CN-101255214-B Diene polymer and process for producing the same SUMITOMO CO LTD 2013-01-02 CN disclosed
EP-1572892-A4 HUMAN GLUCAGON-LIKE-PEPTIDE-1 MIMICS AND THEIR USE IN THE TREATMENT OF DIABETES AND RELATED CONDITIONS BRISTOL MYERS SQUIBB CO (US) 2007-08-22 EP disclosed
US-7161018-B2 Soluble late transition metal catalysts for olefin oligomerizations II EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-01-09 US disclosed
EP-1615653-A2 HUMAN GLUCAGON-LIKE-PEPTIDE-1 MIMICS AND THEIR USE IN THE TREATMENT OF DIABETES AND RELATED CONDITIONS Bristol-Myers Squibb Company (US) 2006-01-18 EP disclosed
EP-1572892-A2 HUMAN GLUCAGON-LIKE-PEPTIDE-1 MIMICS AND THEIR USE IN THE TREATMENT OF DIABETES AND RELATED CONDITIONS Bristol-Myers Squibb Company (US) 2005-09-14 EP disclosed
EP-1513854-A1 SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS Exxonmobil Chemical Patents Inc. (US) 2005-03-16 EP disclosed
WO-2004094461-A2 HUMAN GLUCAGON-LIKE-PEPTIDE-1 MIMICS AND THEIR USE IN THE TREATMENT OF DIABETES AND RELATED CONDITIONS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-11-04 WO disclosed
US-20040039238-A1 Soluble late transition metal catalysts for olefin oligomerizations II EXXONMOBIL CHEMICAL PATENTS INC. 2004-02-26 US disclosed
WO-2003102005-A1 SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2003-12-11 WO disclosed
WO-2003033671-A2 HUMAN GLUCAGON-LIKE-PEPTIDE-1 MIMICS AND THEIR USE IN THE TREATMENT OF DIABETES AND RELATED CONDITIONS BRISTOL-MYERS SQUIBB COMPANY (US) 2003-04-24 WO disclosed
EP-0658162-A1 CARBAPENEM DERIVATIVES AND PROCESSES FOR PREPARING THE SAME DONG-A PHARM. CO., LTD. (KR) 1995-06-21 EP disclosed